ACAD Latest Quarter’s Earnings
Announce Date11/4/2026
EPS Actual (USD)0.31
Revenue Actual (USD)342.29M
ACADIA Pharmaceuticals Inc Earnings Dates & Reports
This page offers detailed ACADIA Pharmaceuticals Inc earnings data including the latest ACADIA Pharmaceuticals Inc earnings report, the upcoming ACADIA Pharmaceuticals Inc earnings date, historical data and ACADIA Pharmaceuticals Inc earnings call news.
ACAD Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
ACAD FY2025 Earnings
EPS (YoY)2.3269.96%
Revenue (YoY)1.07B11.87%
ACADIA Pharmaceuticals Inc (ACAD) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 11/4/2026 | 09/2026 | 0.31/0.20 | 342.29M/332.47M | 58.02% | 2.95% |
| 8/4/2026 | 06/2026 | 0.18/0.06 | 307.96M/295.86M | 219.35% | 4.09% |
| 5/6/2026 | 03/2026 | 0.02/0.06 | 268.06M/280.71M | -65.62% | -4.51% |
| 2/25/2026 | 12/2025 | 1.61/0.14 | 283.99M/292.57M | 1074.36% | -2.93% |
| 11/5/2025 | 09/2025 | 0.43/0.15 | 278.63M/276.47M | 187.26% | 0.78% |
| 8/6/2025 | 06/2025 | 0.16/0.14 | 264.57M/261.81M | 15.94% | 1.05% |
| 5/7/2025 | 03/2025 | 0.11/0.11 | 244.32M/239.34M | 2.18% | 2.08% |
| 2/26/2025 | 12/2024 | 0.86/0.22 | 259.60M/277.65M | 299.40% | -6.50% |
ACADIA Pharmaceuticals Inc Latest Earnings Call Transcripts
Acadia Pharmaceuticals (ACAD) Q3 2026 Earnings Call: DAYBUE Guidance Raised
Acadia Pharmaceuticals Q3 2026 earnings call: revenue rose 22% to $342 million, DAYBUE guidance increased, and remlifanserin advances to Phase III.